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The use of protease-resistant D-peptides is a promi-
nent strategy for overcoming proteolytic sensitivity in
the use of cell-penetrating peptides (CPPs) as deliv-
ery vectors. So far, no major differences have been
reported for the uptake of L- and D-peptides. Here
we report that cationic L-CPPs are taken up more
efficiently than their D-counterparts in MC57 fibro-
sarcoma and HeLa cells but not in Jurkat T leukemia
cells. Reduced uptake of D-peptides co-occurred
with persistent binding to heparan sulfates (HS) at
the plasma membrane. In vitro binding studies of L-
and D-peptides with HS indicated similar binding
affinities. Our results identify two key events in the
uptake of CPPs: binding to HS chains and the in-
itiation of internalization. Only the second event
depends on the chirality of the CPP. This knowledge
may be exploited for a stereochemistry-dependent
preferential targeting of cells.
INTRODUCTION
The use of cell-penetrating peptides (CPPs) such as nona-argi-
nine (R9), TAT, and penetratin as delivery vectors for molecules
that otherwise do not cross the plasma membrane is gaining
significance in biomedicine (Ja¨rver et al., 2010). Although
different strategies are pursued for the optimization of CPP-
based delivery, premature degradation of CPPs before they
reach their target in vivo remains a common concern for thera-
peutic applications (Patel et al., 2007). The relevance of this
concern is exemplified by the rapid degradation of CPPs when
they are in contact with various cell lines (Tre´hin et al., 2004;
Lindgren et al., 2004; Palm et al., 2007) or when they are
exposed to serum (Elmquist and Langel, 2003; Pujals et al.,
2007). A common strategy to combat this issue is to employ
CPPs consisting of D-amino acids (D-CPPs). The altered stereo-
chemistry of peptides containing D-amino acids renders
D-CPPs much more protease resistant than their L-amino acid1000 Chemistry & Biology 18, 1000–1010, August 26, 2011 ª2011 Elcounterparts (Elmquist and Langel, 2003; Pujals et al., 2007;
Youngblood et al., 2007). The increased stability in serum is
not limited to peptides composed entirely of D-amino acids,
but was also observed for partial D-amino acid substitutions at
the termini in small peptides (Tugyi et al., 2005) and for CPPs
conjugated to morpholino-nucleotide oligomers (Youngblood
et al., 2007).
For penetratin, uptake was observed for the reverse L-amino
acid sequence, the D-peptide, and a retro-inverso analog, sug-
gesting that backbone chirality is not important for uptake of this
CPP (Brugidou et al., 1995; Derossi et al., 1996). Because
uptake was also observed at 4C, the authors suggested that
internalization occurred via a receptor-independent mechanism,
most likely involving direct interactions with membrane phos-
pholipids (Derossi et al., 1996). Later studies corroborated this
hypothesis for inverso and retro-inverso analogs of polyargi-
nines and the arginine-rich TAT peptide (Mitchell et al., 2000;
Wender et al., 2000), which together have led to the prevailing
paradigm that cellular uptake of CPPs is a chirality-independent
process. Studies using these and other CPPs, including pVEC
and sweet arrow peptide, provided additional support for this
current paradigm (Elmquist and Langel, 2003; Fretz et al.,
2007; Pujals et al., 2008). A higher uptake efficiency of D-TAT
and D-polyarginines in the presence of serum (Wender et al.,
2000) was attributed to an increased proteolytic stability (Tu¨nne-
mann et al., 2008).
Although the available studies thus appear to sketch a uniform
picture, one should realize that these studies were conducted
with a rather limited number of cell types. It is well established,
however, that different mechanisms for CPP uptake are oper-
ating in different cell types (Mueller et al., 2008). Moreover, some
of the earlier studies did not distinguish between membrane-
bound and internalized peptides. Nowadays, the distinction
between internalized and membrane-associated peptides is
considered a vital aspect for the quantification of CPP uptake
(Burlina et al., 2005; Richard et al., 2003; Oehlke et al., 1998)
and is generally accomplished by a specific modification of the
membrane-bound fraction (Burlina et al., 2005; Oehlke et al.,
1998) or by a trypsin and/or heparin treatment of cells. Because
trypsin does not degrade D-peptides, in studies comparing the
uptake of D- and L-CPPs an incubation of cells with heparin issevier Ltd All rights reserved
Figure 1. Cellular Distribution and Uptake of R9
and r9 in HeLa, MC57, and Jurkat Cells
(A–C) HeLa (A) and MC57 (B) cells were seeded in eight-
well microscopy chambers, grown to 75% confluence,
and incubated with 5 mM of peptides for 45 min. Jurkat
cells (C) were similarly incubated with peptide for 45 min,
washed, and then transferred into the microscopy cham-
bers. Confocal images were acquired immediately.
(D) Illustration of the heparin-induced removal of cell-
associated fluorescence of r9 in living MC57 cells.
Following peptide uptake, cells were incubated twice for
5 min each with 100 mg/ml heparin.
The scale bars represent 10 mm. See also Figure S1.
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Differential Uptake of L- versus D-CPPsthe appropriate treatment for removal of membrane-bound
peptides.
Recent advances in the quantification of internalization, and
the introduction of protocols to study CPP uptake using live-
cell confocal microscopy, warrant a new analysis of L- and
D-CPP uptake. Therefore, the goal of the present study was to
study in detail possible differences in the cellular uptake of argi-
nine-rich as well as cationic amphiphilic all-L CPPs and their
all-D counterparts, using a panel of cell types for which we had
previously noted differences in the intracellular distribution of
CPPs. The CPPs used were nona-arginine (R9), which is consid-
ered to be conformationally unstructured, and the amphiphilic
CPP penetratin, which adopts different conformations depend-
ing on the local environment and also contains several arginine
residues. Furthermore, the human lactoferrin-derived peptide
hLF(38–59) was included (Duchardt et al., 2009). Being entirely
composed of D-amino acids, the inverso peptide D-nona-argi-
nine (r9) is at the same time also the retro-inverso analog of
R9, and as such it is topologically essentially equivalent to R9
with respect to absolute side-chain orientation. For hLF, uptake
efficiency is conformation dependent. Presence of a disulfide
bridge is required for activity (Duchardt et al., 2009).
Surprisingly, we found significant differences in the uptake of
all-L and all-D CPPs in HeLa and MC57 cells, but not in Jurkat
cells. In cells with reduced uptake of D-peptides, a persistent
binding to heparan sulfates (HS) was observed. These differ-
ences in uptake were restricted to uptake via endocytosis. InChemistry & Biology 18, 1000–1010, August 26,contrast, rapid cytoplasmic uptake by nucle-
ation zones, which occurs for R9 and hLF at
higher concentrations (Duchardt et al., 2007),
was even more effective for r9. Detailed binding
studies by surface plasmon resonance (SPR)
and isothermal titration calorimetry (ITC) indi-
cated that D- and L-peptides bound to HS
with similar affinities, suggesting that they also
bind cellular heparan sulfates with similar pro-
pensity and with similar affinities but differ in
their capacity to trigger their endocytic uptake.
Results obtained for a series of peptides with
partial D-amino acid substitutions suggest that
a consecutive stretch of L-amino acids is
required to trigger uptake. The cell-type depen-
dence of the L versus D preference suggests
that the stereochemistry of cationic CPPs maybe exploited as a new principle for a cell type-selective
targeting.
RESULTS
Cellular Uptake of R9 and r9
To address potential differences in the cellular uptake and intra-
cellular trafficking of CPPs (for peptide sequences, see Table S1
available online), we analyzed the uptake and intracellular distri-
bution of R9 and r9 by confocal microscopy in MC57 fibrosar-
coma (Hosaka et al., 1986), HeLa, and Jurkat cells. The selection
of cell lines was motivated by previously observed differences in
cytoplasmic fluorescence at low peptide concentrations, at
which uptake via endocytosis occurs. In MC57 fibrosarcoma
cells, fluorescence was to a larger extent cytoplasmic, whereas
in HeLa cells fluorescence was more restricted to vesicular
structures (Fischer et al., 2004). At low concentrations, fluores-
cence was also strongly cytoplasmic in Jurkat cells and other
leukocytes (Fretz et al., 2007). Uptake and intracellular distribu-
tion were compared after a 45 min incubation with the peptides
at a concentration of 5 mM (Figures 1A–1C).
Unexpectedly, major differences were observed in the uptake
of r9 and R9 in both HeLa (Figure 1A) andMC57 (Figure 1B) cells.
Punctate vesicular structures inside cells were more numerous
and brighter for R9 compared to r9. Next to this punctate stain-
ing, a cytosolic fluorescence was observed for R9 but not for r9
in MC57 and, to a lesser extent, also in HeLa cells for R9. In2011 ª2011 Elsevier Ltd All rights reserved 1001
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Differential Uptake of L- versus D-CPPscontrast, for r9, there was a more intense staining of the plasma
membrane (Figures 1A and 1B). This staining was more
pronounced for MC57 than for HeLa cells. For Jurkat cells, no
membrane staining was present (Figure 1C). Instead, only differ-
ences in the intracellular localization of R9 and r9 were observed.
The distribution of r9 differed from the one of R9 in that the former
strongly stained the nucleoli, in accordance with previous obser-
vations (Fretz et al., 2007). Punctate fluorescent structures, indic-
ative of endocytosis, were not observed in Jurkat cells, even
when concentrations as low as 1 mM were tested.
We and others had previously described that at higher peptide
concentrations, an alternative internalization mechanism occurs
that rapidly leads to cytoplasmic fluorescence (Duchardt et al.,
2007; Fretz et al., 2007; Verdurmen et al., 2010; Kosuge et al.,
2008). Entry occurs through restricted membrane areas by an
acid sphingomyelinase-dependent mechanism (Verdurmen
et al., 2010). The population of cells that shows peptide entry
via this mechanism can be clearly distinguished as cells with
high intensity by flow cytometry. Direct cytoplasmic entry was
reported to be higher for r9 compared to R9 in various cell types,
including HeLa cells (Tu¨nnemann et al., 2008). Here we also
observed a much larger proportion of HeLa cells with high total
fluorescence after being treated with r9 versus R9 at 20 mM (Fig-
ure S1). On the other hand, for r9, flow cytometry histograms
showed the presence of cells with lower fluorescence than
was observed for R9, in agreement with the microscopy data
(Figure 1). These differences indicate that r9 enters more effi-
ciently by direct cytoplasmic entry and less efficiently via endo-
cytosis. It should be noted, however, that a quantitative determi-
nation of peptide uptake by flow cytometry may be hampered by
quenching of fluorescence of fluorophores bound to cellular
structures or present in acidic vesicular compartments.
Quantification of Uptake
Confocal microscopy showed a more pronounced punctate
staining for R9 in comparison to r9 in MC57 and HeLa cells at
a peptide concentration of 5 mM, indicative of amore efficient en-
docytic uptake. To quantitatively confirm these differences, a
quantification method was developed based on fluorescence-
correlation spectroscopy (FCS) in cell lysates in order to over-
come difficulties potentially associated with fluorophore-based
assays. Before lysis, cell-associated fluorescence was removed
by incubation of cells with heparin (Al-Taei et al., 2006), which
proved highly efficient in the removal of surface-bound fluo-
rescence (Figure 1D). However, even after washing off all
membrane-bound peptides, fluorescence intensity could be
influenced by a variety of factors that may differ between R9
and r9. For instance, instead of detecting a genuine difference
in peptide uptake, it was also conceivable that differences in
fluorescence intensity for R9- and r9-treated MC57 cells may
arise due to a higher brightness of the fluorophore when
attached to R9. Moreover, quenching of fluorescence in poten-
tial peptide aggregates could affect peptide quantification.
Furthermore, a fluorescein-labeled degradation product of R9
might be more strongly fluorescent than r9, for which no degra-
dation is expected. Last, differential binding to polyanions, such
as oligonucleotides or protein aggregates, could lead to the
removal of intact peptides during centrifugation steps that are
frequently applied in quantification protocols.1002 Chemistry & Biology 18, 1000–1010, August 26, 2011 ª2011 ElTo address all of the above points, we exploited the capacity
of FCS to provide information on the total fluorescence, particle
number, fluorescence permolecule, and presence of aggregates
(Ruttekolk et al., 2011). Nucleic acids were degraded with
benzonuclease, followed by complete degradation of all pro-
teinaceous components by proteinase K (Figure S2). When we
quantified the intracellular fluorescence of R9 and r9 with the
above-described protocol, the uptake of r9 was only 21% that
of R9. Even when we corrected for detection efficiency (see
legend of Figure S2), the uptake of r9 was still only 36% com-
pared to uptake of R9, supporting the observation that peptide
uptake is indeed more efficient for R9. Notably, also, the interac-
tion with HS chains that will also be present in lysates did not
significantly alter the fluorescence of R9 and r9 (Figure S3).
Due to the complexity of the FCS-based method, we also used
a simpler fluorimetry method to assess peptide internalization.
With this method, we found that uptake of r9 was 46% ± 2% that
of R9 in MC57 cells, and comparable observations were made
for HeLa cells (53% ± 1%), whereas no significant differences
were observed in Jurkat cells (91% ± 8% r9 compared to R9).
Another factor possibly contributing to the observed differ-
ences in cellular uptake was the structural environment of the
fluorophore. Because r9 corresponds to a retro-inverso R9,
coupling of the fluorophore to the C terminus of r9 should even
more closely mimic R9. However, very similar cellular distribu-
tions of fluorescence were found for (1) an N-terminally carboxy-
fluorescein-labeled and C-terminally amidated r9, and (2) an
N-terminally acetylated and C-terminally amidated r9, for which
the carboxyfluorescein moiety was attached to a C-terminal
lysine (Fischer et al., 2003) (Figure S4A), demonstrating that
the position of the fluorophore does not explain the differences
in distribution and uptake between r9 and R9.
Peptide Export
Another factor that may lead to a different distribution and
amount of cell-associated fluorescence is the rate of export of
either the CPP or its degradation products. To investigate
whether R9 or its degradation products were retained more effi-
ciently in HeLa or MC57 cells over the 1 hr time course of the
experiments, these cells were electroporated with a 5 mM solu-
tion of either R9 or r9 (Figures S4B and S4C). Electroporation
delivers a pulse of peptides directly into the cytosol. Therefore,
this method is well suited to follow the release kinetics of mole-
cules. Both the images per se and the image-based quantifica-
tion of the mean intracellular fluorescence illustrate that no rele-
vant differences could be detected in the export of R9 and r9
after 30 min and 1 hr, both in MC57 and in HeLa cells. This result
indicates that a differential export is also not a likely reason for
the observed differences.
Difference in Uptake of Other Cationic L- and D-CPPs
in HeLa and MC57 Cells
To investigatewhether the differences in uptakewere restricted to
thepolyargininesR9and its all-Dcounterpart orwere also valid for
other types of cell-penetrating peptides, we compared the uptake
of the L- and D-forms of the CPPs penetratin and hLF, cor-
responding to amino acids 38–59 of human lactoferrin (Duchardt
et al., 2009), in HeLa and MC57 cells (Figures 2A and 2B). For
bothof theseL-peptidesand theirD-counterparts, theD-peptidessevier Ltd All rights reserved
Figure 2. Differences in Uptake Are Observed
for Various Different CPPs and Are Not Explained
by the Stability of D-Peptides against Cysteine
Proteases
(A and B) For all experiments, cells were seeded in eight-
well microscopy chambers, grown to 75% confluence,
and incubated with 5 mM of each peptide. Cells were
washed twice and confocal images were taken immedi-
ately. HeLa andMC57 cells were incubated for 45minwith
L- or D-penetratin (A) or for 30 min with L- or D-hLF (B).
(C and D) MC57 cells were preincubated with 40 mME-64d
before a 45 min CPP incubation in the presence or
absence of E-64d with R9 or r9 (C) or with L- or D-pene-
tratin (D).
The scale bars represent 10 mm.
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in MC57 cells, in agreement with the observations for the nona-
arginine peptides. For hLF, membrane-bound fluorescence was
observed for both stereoisomers, but endocytosis of D-hLF was
clearly reduced, as quantitatively confirmed by measuring the
intracellular fluorescence in cell lysates (see below).
Effects of Intracellular Stability on Peptide Localization
Previously, we reported that under conditions where endocy-
tosis was the dominant route of uptake the cytoplasmic fluores-
cence, but not the vesicular fluorescence, of L-penetratin in
MC57 cells was reduced by the broad-range cysteine protease
inhibitor E-64d (Fischer et al., 2010). Cysteine proteases of the
cathepsin family are a major part of proteolytic activity in the en-
dolysosomal compartment. Therefore, the result indicated that
fluorescein-bearing proteolytic fragments escape the endosome
more efficiently than intact peptides. We thus reasoned that the
differences in distribution of intracellular fluorescence of D- and
L-peptides observed by confocal microscopymight be related to
the intracellular stability of the peptides. To investigate this
possibility, MC57 cells were incubated with E-64d and treated
with either R9 or r9. Similar to our previous results, we observed
that cytoplasmic fluorescence upon R9 and L-penetratin treat-
ment was completely abolished by E-64d (Figures 2C and 2D).
However, vesicular fluorescence was unaffected. Moreover, no
effect on the distribution of either D-CPP was apparent. These
results indicate that the cytoplasmic fluorescence but not the
differences in vesicular fluorescence are related to intracellular
CPP stability.
Stimulation of Uptake of Fluorescein-Labeled r9
by Unlabeled R9/r9
We and others had demonstrated that CPPs can actively induce
endocytosis (Fotin-Mleczek et al., 2005; Kaplan et al., 2005). We
therefore tested whether endocytosis of r9 could be increasedChemistry & Biology 18, 1000–1010, August 26,by coincubation with unlabeled R9. However,
no increased internalization of r9 could be
observed (Figure S5A).
Role of HS Chains in Membrane Binding
and Cellular Uptake of L- versus D-CPPs
Heparan sulfate chains have been shown to
interact with arginine-rich cell-penetratingpeptides (Gonc¸alves et al., 2005; Ziegler and Seelig, 2004) and
to play a role in the uptake of CPPs (Nakase et al., 2004; Richard
et al., 2005). We therefore hypothesized that binding of peptides
to HS chains might contribute to the different uptake of L- and
D-peptides. If this was the case, one consequence would be
that Jurkat cells, for which no differences in uptake were
observed, should expose fewer HS chains on their surface
than MC57 and HeLa cells. Furthermore, removal of HS chains
by heparinase should reduce the absolute difference in peptide
uptake.
In order to test these predictions, first, the presence of HS
chains on three cell types was investigated by immunofluores-
cence. Immunofluorescence staining of all three cell lines was
conducted both separately (Figure 3A) and, in order to ensure
maximum comparability of signal intensities, also in one sample
(Figure 3B). In accordance with our prediction, there was a clear
correlation between the presence of HS and the preference for
internalization of R9 over r9. HS chains were present on MC57
cells and on HeLa cells, but were undetectable on Jurkat cells.
To further investigate whether the membrane staining of the
D-CPPs observed for MC57 and HeLa cells represented
peptides binding to HS, MC57 cells were treated with hepa-
rinases to remove HS chains from the cell surface (Figure 3C).
For r9, heparinase pretreatment of cells abolished membrane-
bound fluorescence. Only little punctate fluorescence inside
the cells was still observed. For R9, heparinase treatment had
very little effect on the distribution of fluorescence. Instead, there
was a reduction in the intensity of the cytoplasmic fluorescence,
demonstrating a reduction of uptake. In order to quantitatively
investigate these differences, cellular peptide uptake in all
three cell lines was quantitated by fluorimetry after removal of
membrane-bound peptides (Figures 3D–3F). Consistent with
the microscopy data, after heparinase treatment a clear trend
was visible showing a greater absolute decrease of R9 than r9
in HS-rich MC57 and HeLa cells, and for L-hLF compared to2011 ª2011 Elsevier Ltd All rights reserved 1003
Figure 3. Role of HS Chains in CPP Binding and Uptake
(A) Detection of HS on HeLa, MC57, and Jurkat cells. MC57 cells and HeLa cells were seeded in eight-well microscopy chambers, and Jurkat cells were obtained
from a culture flask at the start of the experiment. All three cell lines were probed for HS chains by indirect immunofluorescence of living cells. The scale bar
represents 40 mm.
(B) Parallel detection of HS onHeLa,MC57, and Jurkat cells. MC57 cells were distinguished by CFSE labeling and seeded together with HeLa cells in an eight-well
microscopy chamber. Jurkat cells were stained according to the same procedure in parallel and seeded in the wells after the final washing steps. Jurkat cells
could be detected based on their size and morphology. In the control, only the secondary antibody was applied. The scale bar represents 10 mm.
(C) Effect of HS chain removal on the uptake and distribution of R9 and r9 in MC57 cells. MC57 cells were pretreated with heparinases for 1 hr or left untreated.
Cells were washed and incubated with 5 mM indicated peptide for 45 min. HS chains were labeled by indirect immunofluorescence of living cells. The scale bar
represents 20 mm.
(D–F) Quantification of the impact of HS chain removal on peptide uptake. HeLa, MC57, and Jurkat cells were pretreated with heparinases (+) for 1 hr to remove
HS chains or left untreated (), washed, and incubated for 45 min with 5 mM of the indicated peptide. Subsequently, cells were washed with heparin to remove
membrane-bound peptides, lysed, and centrifuged. Fluorescence in the supernatant was measured using a microplate reader. The fluorescence of R9 (D) and
L-hLF (E) in untreated cells was set at 100% to aid comparison with the treated peptides or analogs. In (F), the effect of a heparinase treatment on uptake of R9
and r9 (left bars), and other L-CPPs and D-CPPs (right bars) (analysis includes L/D-penetratin and L/D-hLF), is depicted as the ratio of uptake before and
after a heparinase treatment in cells expressing heparan sulfates. Error bars indicate the mean ± SEM. *p < 0.05. See also Figure S2.
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Differential Uptake of L- versus D-CPPsD-hLF in HeLa cells. A combined statistical analysis of the HS-
rich HeLa and MC57 cells demonstrated that the absolute
decrease of R9 after heparinase treatment was greater than for
r9 (p < 0.01). When data for L- and D-hLF were also included in
this analysis, the different effects of heparinase treatment on1004 Chemistry & Biology 18, 1000–1010, August 26, 2011 ª2011 Elthe uptake of L- and D-peptides were even more significant
(p < 0.001), arguing that the absolute decrease of uptake of
L-CPPs was significantly more affected by a heparinase treat-
ment in HS-rich cells. In line with these findings, the effect of
HS chain removal on r9 internalization was nonsignificant.sevier Ltd All rights reserved
Figure 4. Interaction between HS and L- and D-CPPs as Determined
by SPR and ITC
(A–D) SPR diagrams of D- and L-peptide binding to immobilized HS. Peptides
and concentration ranges are indicated.
(E–H) ITC of the interaction between HS and L- and D-CPPs. The raw ITC
graphs show the reference power as a function of time over the course of
a single representative experiment, where 1 ml injections of 30 mM HS were
added to 200 ml of 20 mMR9or r9 in the sample cell. The ITC graphs in the lower
panels show the integrated heats per HS injection, expressed as heat per in-
jected mole of HS, as a function of the molar ratio of HS and peptide in the cell.
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Having shown that heparan sulfates contribute to the effective-
ness of peptide entry, especially of L-peptides, it was still unclear
at this point whether heparan sulfates serve as mere attachment
factors or as true receptors with an active role in the induction of
internalization. Themajor reason for the inability to directly distin-
guish between these roles is that both mechanisms would
contribute to the effectiveness of peptide entry. Similar practical
problems are encountered when trying to distinguish between
attachment factors and receptors in elucidating the entry mech-
anisms of viruses (Mercer et al., 2010).
To probe for differences in the interaction between heparan
sulfates and L- and D-CPPs, we first conducted SPR spectros-
copy with immobilized heparan sulfate. With SPR, a slightly
higher affinity of r9 for HS chains was observed compared to
R9, whereas affinities for L- and D-penetratin were very similar
(Figures 4A–4D and Table 1). With ITC, too, similar KD values
were obtained for both peptide pairs, although these values
differed somewhat from those obtained with SPR (Figures
4E–4H and Table 1). Notably, the stoichiometry, enthalpy
(DH), and entropy (DS), but not the KD, were changed slightly
for r9 compared to R9, indicative of a somewhat different
mode of binding. In contrast, for L- and D-penetratin, the contri-
butions of enthalpy and entropy, as well as the stoichiometry
and binding affinity, were all very similar. Therefore, it is very
unlikely that the slight differences in HS binding observed for
R9 and r9 underlie the pronounced differences in behavior of
these peptides at the plasma membrane in HeLa and MC57
cells.
Nitric Oxide and Uptake
As a further potential molecular mechanism to explain the differ-
ences in the uptake of arginine-containing L- and D-peptides,
we examined the involvement of nitric oxide formation. L-argi-
nine released from L-peptides through proteolysis may serve
as a substrate for nitric oxide generation by nitric oxide syn-
thase. Nitric oxide is a free radical that can lead to cellular
stress and the activation of stress-induced P38, which could
in turn stimulate endocytosis (Sorkin and von Zastrow, 2009).
Cells were incubated with the nitric oxide synthase inhibitor
N(G)-nitro-L-arginine methyl ester (L-NAME). The differences
in uptake efficiency that were observed for R9 and r9 were
very minor (Figure S5B), indicating the absence of a pivotal
role for nitric oxide generation in the differences in uptake of
R9 and r9.
Uptake of L/D-Chimeras of Nona-Arginine inMC57 Cells
Having strong indications that L- and D-CPPs differ with respect
to triggering their uptake, wewere interested to learnmore about
the structure-activity relationship of this trigger. Therefore, inter-
nalization of L/D-chimeras of nona-arginine was assessed in
MC57 cells (Figure 5). When only the C- and N-terminal L-amino
acids were exchanged for D-amino acids, endocytic internaliza-
tion still occurred, but cytoplasmic fluorescence was abolished.
In contrast, when multiple L-amino acids were mutated to
D-amino acids, a persistent membrane binding was observed,
resembling the phenotype of r9. These data suggest that
a consecutive stretch of L-amino acids is required to trigger effi-
cient endocytic uptake.Chemistry & Biology 18, 1000–DISCUSSION
According to the paradigm, chirality does not play a role in the
uptake of CPPs. However, here we demonstrate a clear chirality1010, August 26, 2011 ª2011 Elsevier Ltd All rights reserved 1005
Table 1. Results of SPR and ITC Binding Studies between HS and L- and D-CPPs
SPR ITC
Peptide KD (mM) KD (mM) Stoichiometry DH (kcal mol
1) DS (kcal mol1 K1)
R9 0.30 ± 0.13 0.14 ± 0.04 8 ± 1 99 ± 4 0.32 ± 0.01
r9 0.19 ± 0.06 0.16 ± 0.01 11 ± 1 129 ± 7 0.43 ± 0.03
L-penetratin 0.53 ± 0.15 0.15 ± 0.02 10 ± 3 78 ± 11 0.25 ± 0.05
D-penetratin 0.48 ± 0.02 0.16 ± 0.03 10 ± 3 89 ± 9 0.29 ± 0.03
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arginine, hLF, and penetratin. Differences in internalization were
observed in MC57 and HeLa cells in a concentration range for
which endocytosis dominates the uptake of arginine-containing
CPPs (Duchardt et al., 2007). No differences were observed in
Jurkat cells, in agreement with previous observations (Wender
et al., 2000).
The preference for L-peptides was only observed in cells con-
taining significant amounts of heparan sulfates on the plasma
membrane. On these cells, D-CPPs of nona-arginine, penetratin,
and hLF remained strongly membrane associated, whereas no
such prominent association was observed in HeLa cells for the
corresponding L-CPPs, except for L-hLF. Also, only in these
HS-positive cell types was the internalization of L-CPPs higher
compared to D-CPPs. The importance of the chirality of the
amino acids was further underscored by the use of two nona-
arginine chimeras composed of D- and L-amino acids that
showed different phenotypes of internalization, depending on
the position and number of D-amino acids. For nona-arginine,
HS was identified as an important interaction partner in MC57
cells, as its removal reduced the membrane binding of r9. Addi-
tionally, HS chain removal had a greater absolute effect on the
internalization of all-L CPPs in comparison to all-D CPPs in
MC57 and HeLa cells.
Heparan sulfates have recently been proposed as receptors
for arginine-rich peptides (Nakase et al., 2004; Richard et al.,
2005). This view is based on the observation that arginine-rich
CPPs, upon their interaction with HS proteoglycans, induce actin
rearrangements typical for macropinocytosis (Nakase et al.,
2004). In our study, SPR and ITC binding assays indicated
marginal differences in the binding of the various arginine-con-
taining L- andD-CPPs toHS, supporting the notion that HS serve
primarily as attachment factors instead of true receptors in
MC57 and HeLa cells. As a consequence, the recognition event
at the plasma membrane, which is responsible for the more effi-
cient internalization of L-CPPs versus D-CPPs, remains un-
known at present. Because the internalization of L- and D-
CPPs was much more similar after removal of HS chains, it is
reasonable to speculate that the presence of HS chains strongly
facilitates this unknown interaction. One prominent possibility is
the presence of a protein receptor that carries HS chains, such
as the recently proposed syndecan-4 (Letoha et al., 2010). An
involvement of a protein factor associated with internalization
of CPPs is supported by studies in CHO cells, in which the selec-
tive removal of glycosaminoglycans only partially reduced inter-
nalization, whereas trypsin treatment almost completely abol-
ished internalization via endocytosis (Gump et al., 2010). A
distinction between binding and internalization has also recently
been observed for HS chain-directed single-chain variable-1006 Chemistry & Biology 18, 1000–1010, August 26, 2011 ª2011 Eldomain antibody fragments (scFv). Only one scFv of several
tested was efficiently internalized, whereas others remained
membrane bound (Wittrup et al., 2009). Remarkably, we were
not able to stimulate uptake of labeled r9 by the addition of unla-
beled R9, even though it had been previously shown that CPPs
can actively induce endocytosis (Fotin-Mleczek et al., 2005;
Kaplan et al., 2005). These data indicate that both isomers
behave as distinct molecular entities at the plasma membrane.
Interestingly, similar results were reported for the induction of
nucleation zone-dependent uptake (Tu¨nnemann et al., 2008).
Intracellular degradation (Fischer et al., 2004, 2010; Ha¨llbrink
et al., 2004) and reexport (Oehlke et al., 1998) have been shown
to affect the cellular distribution and intracellular retention time
of CPPs. Moreover, the sensitivity of the fluorescence of the
fluorescein moiety to the chemical environment, for example
pH or hydrophobicity, and to collision quenching with neigh-
boring groups is well known. In addition, careful preparation of
lysates is an important factor when comparing numbers of fluo-
rophores from intact D- and (partially) degraded L-peptides. In
our experiments, we could exclude all of these factors as
a source of the observed differences. However, the cytoplasmic
fluorescence observed after treatment of cells with L-peptides
under conditions where endocytosis is the dominant route of
uptake very likely relates to their proteolytic sensitivity, as R9-
or L-penetratin-incubated cells were devoid of cytoplasmic fluo-
rescence after pretreatment with the endolysosomal protease
inhibitor E-64d (Figure 2). We had previously reported the
same observation for L-penetratin (Fischer et al., 2010). Quite
remarkably, the internalization pattern of an R9 analog with
terminal D-amino acids reflected the same pattern observed
with R9 after pretreatment with E-64d. We thus conclude that
the terminal D-amino acids were sufficient to inhibit proteolysis
in endocytic vesicles, whereas the central stretch of seven
consecutive L-amino acids was sufficient to induce endocytosis
effectively.
Extracellular peptide degradation is also a very unlikely cause
of differences in the internalization, as shorter oligo-arginine
fragments (<R9) are taken up with a considerably lower effi-
ciency (Wender et al., 2000). Regarding the heparin treatment
we used, it may not have removed membrane-bound peptides
completely, but this would only have led to an overestimation
of the internalization of D-peptides.
The reason for the higher proportion of HeLa cells showing
internalization of r9 via direct translocation is not necessarily
a consequence of a greater stability toward proteolytic activity.
Instead, the reduction of internalization via endocytosis might
accelerate accumulation of peptide at the plasma membrane,
which might trigger direct translocation more rapidly. Consistent
with this hypothesis, the concentration threshold at which thesevier Ltd All rights reserved
Figure 5. Uptake of R9, r9, and Nona-Arginine
Chimeras Composed of L- and D-Amino Acids in
MC57 Cells
Cells were seeded in eight-well microscopy chambers,
grown to 75% confluence, and incubated with 5 mM of the
indicated peptides for 45 min. Cells were washed twice
and confocal images were taken immediately. The scale
bar represents 10 mm. See also Figure S5.
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Differential Uptake of L- versus D-CPPsdirect translocation occurs could be lowered by incubation of
cells with endocytosis inhibitors (Duchardt et al., 2007).
Even though our results clearly refute the earlier paradigm of
a chirality-independent uptake of CPPs, our results do not
contradict earlier findings. Instead, prior experiments had been
designed in such a way that they missed these differences. In
accordance with previous findings, we did not detect a differ-
ence in the uptake of R9 and r9 in Jurkat cells (Wender et al.,
2000). When Tu¨nnemann et al. compared the uptake of R9
and r9, they only focused on the number of cells that showed
rapid translocation across the membrane (Tu¨nnemann et al.,
2008).Chemistry & Biology 18, 1000–1010, August 26,It should also be pointed out that differences
were previously reported for molecular com-
plexes containing L- and D-CPPs. Mason et al.
found a reduced transfection efficiency for
DNA complexes containing the amphipathic
peptide D-LAH4 compared to L-LAH3 (Mason
et al., 2007), and Abes et al. found a re-
duced biological activity of morpholino-olig-
omer-peptide complexes with partial D-amino
acid substitutions (Abes et al., 2008). Remark-
ably, retro-inverso CPPs were much more toxic
to cells, demonstrating that despite very similar
side-chain orientations, these peptides also
induced very different biological responses
(Holm et al., 2011). Although these studies indi-
cate a different behavior for peptides containing
D-amino acids, none of these studies had
explicitly addressed the impact of chirality on
internalization efficiency.
Taken together, our findings indicate that cell-
surface binding and the induction of internaliza-
tion are distinct mechanisms with individual
structure-activity relationships. For the CPPs
nona-arginine, penetratin, and the hLF peptide,
our data indicate that binding to heparan
sulfates is chirality independent, whereas the
efficiency of internalization is related to chirality.
We envision that these findings will have impor-
tant consequences for the use of L- and
D-amino acids in drug delivery strategies in
general.
The cell line dependence of our results also
suggests a potential to employ the HS-depen-
dent discrimination of CPPs for tissue-selective
targeting. The preferential uptake of arginine-
containing L-CPPs by cells expressing HS
may be exploited for a preferential targeting ofthese cells. Conversely, targeting to cells not expressing HS
can be more easily accomplished with CPPs synthesized with
D-amino acids.
SIGNIFICANCE
Cell-penetrating peptides (CPPs) represent a class of short,
usually cationic peptides that efficiently induce cellular
uptake of large membrane-impermeable macromolecules.
However, an important factor limiting the pharmacological
potential of CPPs is their proteolytic instability, which can
be overcome through incorporation of D-amino acids.2011 ª2011 Elsevier Ltd All rights reserved 1007
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differences in the uptake efficiency of the L- and D-form of
three arginine-containing CPPs. These differences can be
understood in terms of a two-step internalization process
of CPPs at low concentrations: first, binding to heparan
sulfates (HS) on the plasma membrane; second, internaliza-
tion by endocytosis. Our data indicate that in the presence of
HS chains only the second step occurs less efficiently for
D-CPPs and can therefore be considered chirality depen-
dent. Data supporting this hypothesis include (1) the correla-
tion of a more efficient internalization of L-CPPs with the
expression of HS, and (2) the pronounced membrane fluo-
rescence of D-CPPs, but not L-CPPs, in HS-expressing cells,
which can be eliminated by a heparinase treatment. More-
over, HS removal affects mainly the internalization of
L-CPPs in cell lines with high levels of HS. We could exclude
alternative interpretations of the observed differences
through a comprehensive set of control experiments. Even
though our results disagree with the current paradigm of
an equal efficiency of L- and D-CPPs, our results do not
contradict any published findings, as these previous re-
sults addressed differences for only a limited set of condi-
tions. For in vivo applications, the balance of in vivo pro-
teolytic stability, cellular internalization efficiency, and
intracellular trafficking may ultimately be decisive. Results
obtained for chimeric L/D-peptides revealed an interesting
structure-activity relationship. It will be interesting to
explore to what degree such peptides containing only
a few D-amino acids may combine the high stability of
all-D CPPs with the higher uptake of arginine-containing
all-L CPPs.
EXPERIMENTAL PROCEDURES
Materials
All-L and all-D peptides were purchased from EMC Microcollections.
Chimeric peptides (R9 [1,9] and R9 [1,3,5,7,9]) were synthesized using stan-
dard Fmoc/OtBu solid-phase peptide synthesis protocols on a rink amide
resin. Each amino acid was coupled using HOBt/HBTU in the presence of
N,N0-diisopropylethylamine (DIPEA) as a base. Peptides were cleaved from
the resin using TFA:triisopropylsilane:H2O (92.5:5:2.5, v:v:v) and the crude
peptides were purified on C18 reverse-phase HPLC columns using water/
acetonitrile gradients. N-terminal fluorophore labeling was performed using
5(6)-carboxyfluorescein as previously described (Fischer et al., 2003).
Peptides were synthesized C-terminally amidated and N-terminally fluores-
cein labeled, unless stated otherwise. Purity was evaluated by analytical
HPLC and identity was confirmed by mass spectrometry. hLF peptides
were oxidized by purging oxygen through the peptide solution for 5 min, fol-
lowed by a 2 hr incubation at 37C. Oxidation leads to cyclization by disul-
fide-bridge formation.
The Zenon mouse IgG1 labeling kit was from Invitrogen; BSA, octyl-b-D-
glucopyranoside, heparin, and glucose were from Sigma-Aldrich. Heparan
sulfate (average MW 15 kDa) was from Celsus. Heparinases I–III were
purchased from IBEX. The anti-HS VSV-tagged single-chain Fv fragment
HS4C3V was described previously (van Kuppevelt et al., 1998), and the
mouse anti-VSV (clone P5D4) antibody was from Boehringer Mannheim.
E-64d was from Bachem. Standard chemicals were from Sigma-Aldrich and
Merck.
Cell Culture
All cell lines were maintained in RPMI 1640 (PAN Biotech) supplemented with
10% heat-inactivated fetal calf serum (PAN Biotech) and passaged every
2–3 days. Cells were incubated at 37C in a 5% CO2, humidified incubator.1008 Chemistry & Biology 18, 1000–1010, August 26, 2011 ª2011 ElConfocal Laser-Scanning Microscopy and Fluorescence-
Correlation Spectroscopy
Confocal laser-scanning microscopy and FCS were performed on a TCS SP5
confocal microscope (Leica Microsystems) equipped with an HCX PL APO
633 NA 1.2 water immersion lens and a dual-channel FCS unit. Fluorescein
fluorescence was excited with the 488 nm line of an argon ion laser. Detection
took place with a 500–550 nm filter block for FCS measurements and with
a 500–550 nm detection range for confocal microscopy. Cells weremaintained
at 37C on a temperature-controlled microscope stage.
Peptide Uptake
MC57 and HeLa cells were seeded in eight-well microscopy chambers (Nunc)
and grown to 75% confluence. Jurkat cells were transferred from the tissue
culture flask immediately before the experiment. Cells were incubated at
37C with 5 mM peptides in RPMI 1640 supplemented with 10% fetal calf
serum. The duration of incubations is indicated for each experiment sepa-
rately. Cells were washed twice with medium after the incubation with
peptides, and living cells were analyzed immediately or after settling for about
15 min in the microscopy chambers (Jurkat cells) by confocal microscopy.
Removal of HS chains from the cell surface was accomplished by a 1 hr incu-
bation at 37C with RPMI 1640 supplemented with 1% fetal calf serum,
33 mIU/ml of heparinase I, 8 mIU/ml of heparinase II, and 5 mIU/ml of
heparinase III.
Quantification of Cellular Uptake
After incubation with the peptides, cells were washed with prewarmed
HEPES-buffered saline (HBS)/BSA/glucose (10 mM HEPES, 135 mM NaCl,
5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2 [pH 7.4], containing 0.1% [w/v]
BSA and 5 mM glucose), treated twice for 5 min at 37C with 100 mg/ml
heparin in HBS/BSA/glucose, and washed again with HBS/BSA/glucose.
Cells were then lysed in 150 ml lysis buffer (10 mM bis-Tris propane, 50 mM
octyl-b-D-glucopyranoside, 1 mM EDTA, and 150 mM NaCl [pH 7.2]) for
15 min on ice; the lysate was centrifuged for 10 min at 18,000 3 g and the
fluorescence in 120 ml of the supernatant was measured using a Synergy 2
microplate reader (Biotek) by excitation at 488 ± 10 nm and detection at
528 ± 10 nm in a flat-bottom 96-well plate (Nunc). Values were corrected
for total protein content on the basis of results from the Bio-Rad protein assay
in microtiter plates with the dye reagent from Bio-Rad. For quantification by
FCS, 150 ml of lysate was treated with 2 ml of benzonuclease (2U; Novagen,
Merck) for 30 min at 37C, followed by a 3 hr incubation with 3.3 mg/ml
proteinase K (diluted from a 20 mg/ml stock; Roche) at 37C. For a detailed
description of the FCS analysis, please refer to Supplemental Experimental
Procedures.
Immunofluorescence
Cells were washed with ice-cold HBS/BSA/glucose and incubated with 125 ml
of a periplasmic fraction containing the anti-HS single-chain Fv fragment
HS4C3V for 1 hr on ice in eight-well microscopy chambers (MC57 and HeLa
cells) or in the same volume in Eppendorf tubes (800,000 Jurkat cells). After
incubation, cells were washed again with ice-cold HBS/BSA/glucose and
incubated for 1 hr with an anti-VSV antibody (P5D4)/Zenon IgG1-Alexa Fluor
647 conjugate on ice. The antibody staining was analyzed by confocal
microscopy. When coseeding MC57, HeLa, and Jurkat cells, MC57 cells
were distinguished from HeLa cells using the Celltrace carboxyfluorescein
diacetate succinimidylester (CFSE) proliferation kit (Molecular Probes, Invitro-
gen) according to the manufacturer’s instructions.
Pulse-Chase Experiment
MC57 and HeLa cells were detached by trypsinization for 5 min and incubated
with prewarmed RPMI 1640 supplemented with 10% fetal calf serum. One
million cells were mixed with 5 mM indicated peptide and immediately electro-
porated using the Amaxa nucleofector kit R (Lonza), according to themanufac-
turer’s instructions. After electroporation, cells were washed twice with
medium and 125,000 cells per well were seeded in eight-well microscopy
chambers. Confocal images were taken 30 min and 1 hr after electroporation.
Mean intracellular fluorescence was quantitated using the ImageJ software
package (http://rsb.info.nih.gov/ij).sevier Ltd All rights reserved
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HeLa cells were seeded in 24-well plates (Sarstedt) at a density of 40,000 cells/
well 2 days prior to the experiment. For experiments probing for an involve-
ment of NO synthase in uptake differences, cells were incubated for 30 min
with or without 200 mM L-NAME in RPMI 1640 without serum followed by
a 30 min incubation with 5 or 10 mM R9 in the presence or absence of
200 mML-NAME in serum-containing RPMI. Subsequently, cells were washed,
detached by trypsinization for 5 min, spun down, and resuspended in 200 ml
HBS, and cellular fluorescence was measured using a BD FACScan flow
cytometer equipped with a 488 nm laser (BD Biosciences). The analysis was
performed using Summit software (Dako). Results were based on 10,000
gated cells.
Surface Plasmon Resonance and Isothermal Titration Calorimetry
SPR and ITCwere performed on a Biacore 2000 (GE Healthcare) and an ITC200
system (MicroCal), respectively. For detailed protocols regarding these tech-
niques, see Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at doi:
10.1016/j.chembiol.2011.06.006.
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